SymBio Pharmaceuticals Ltd
TSE:4582
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SymBio Pharmaceuticals Ltd
TSE:4582
|
JP |
|
M
|
Matichon PCL
SET:MATI
|
TH |
|
Uni-Asia Group Ltd
SGX:CHJ
|
HK |
|
EPL Ltd
NSE:EPL
|
IN |
|
Obayashi Corp
TSE:1802
|
JP |
|
E
|
Espey MFG & Electronics Corp
AMEX:ESP
|
US |
|
Betonjaya Manunggal Tbk PT
IDX:BTON
|
ID |
|
G
|
Greencore Group PLC
F:GCG
|
IE |
|
M
|
Murata Manufacturing Co Ltd
XMUN:MUR1
|
JP |
|
Logitech international SA
F:LTEC
|
CH |
|
H
|
Halliburton Co
SWB:HAL
|
US |
|
Constellation Software Inc
TSX:CSU
|
CA |
|
Bald Eagle Gold Corp
XTSX:BIG
|
CA |
|
Z
|
Zimmer Biomet Holdings, Inc
SIX:ZBH
|
US |
|
Bloomin' Brands Inc
NASDAQ:BLMN
|
US |
|
L
|
Lighthouse Properties PLC
JSE:LTE
|
MT |
|
S
|
Stantec Inc
F:S3A
|
CA |
|
El En SpA
F:EE5
|
IT |
|
loanDepot Inc
NYSE:LDI
|
US |
|
Strongpoint ASA
F:PGT
|
NO |
|
Korro Bio Inc
NASDAQ:KRRO
|
US |
|
M
|
MS&AD Insurance Group Holdings Inc
DUS:59M
|
JP |
|
Diamcor Mining Inc
XTSX:DMI
|
CA |
|
Ural'skaya Kuznitsa PAO
MOEX:URKZ
|
RU |
Shareholder Yield
Current shareholder yield for SymBio Pharmaceuticals Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
SymBio Pharmaceuticals Ltd
| Average Annual Return | -43.26% |
| Standard Deviation of Annual Returns | 16.43% |
| Max Drawdown | -97% |
| Market Capitalization | 4.6B JPY |
| Shares Outstanding | 80 230 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
SymBio Pharmaceuticals Ltd's latest stock split occurred on Jun 26, 2019
The company executed a 1-for-4 stock split, meaning that for every 4 shares held, investors received 1 new share.
Before the split, SymBio Pharmaceuticals Ltd traded at 159 per share. Afterward, the share price was about 673.
The adjusted shares began trading on Jun 26, 2019. This was the only stock split in SymBio Pharmaceuticals Ltd's history.